GSK sees blockbuster potential in targeted cancer therapy after promising early data
British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early
April 12, 2026
S&P 500, Dow futures inch up after Wall Street's best month in years
Japan may have spent $35 billion in yen-buying intervention, BOJ data shows
Reddit rallies as AI‑driven ad growth fuels strong revenue outlook
Oscar statuette for 'Mr. Nobody Against Putin' goes missing on flight
Jaden McDaniels and the feisty Timberwolves oust the Nuggets and move on to meet the Spurs
King Charles charms America and avoids pitfalls during his four-day whirlwind US tour